Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald J M
Department of Experimental Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Institute, Vancouver, British Columbia, Canada.
PLoS One. 2015 Sep 3;10(9):e0136065. doi: 10.1371/journal.pone.0136065. eCollection 2015.
The combination of asthma and chronic obstructive pulmonary disease (COPD), or ACOS is a recently defined syndrome. The epidemiology of the condition is poorly described and previous research has suggested ACOS is associated with worse outcomes than either condition alone. We therefore decided to complete a systematic review of the published literature.
This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta- Analyses guidelines. A structured search was performed in the PubMed, Embase, and Medline databases up to Feb 2015 to identify studies reporting incidence, prevalence, health care utilization, morbidity, or mortality in COPD and asthma.
A total of 19 studies were included in the present study. The pooled prevalence of overlap among COPD was 27% (95% CI: 0.16-0.38, p<0.0001) and 28% (95% CI: 0.09-0.47, p = 0.0032) in the population and hospital-based studies, respectively. We found no significant difference between ACOS and COPD in terms of gender, smoking status, lung function and 6mWD. However, in comparison to subject with only COPD, ACOS subjects were significantly younger, had higher BMI, healthcare utilization, and lower HRQoL.
ACOS is a common condition that exists in a substantial proportion of subjects with COPD. ACOS represents a distinct clinical phenotype with more frequent exacerbations, hospitalization, worse health-related quality of life, and higher healthcare costs than either disease alone. There is a critical need to better define the management and treatment of this syndrome.
哮喘与慢性阻塞性肺疾病(COPD)的合并症,即哮喘 - 慢性阻塞性肺疾病重叠综合征(ACOS)是一种最近定义的综合征。该疾病的流行病学描述较少,先前的研究表明,ACOS与比单独任何一种疾病更差的预后相关。因此,我们决定对已发表的文献进行系统评价。
本评价按照系统评价和Meta分析的首选报告项目指南进行。截至2015年2月,在PubMed、Embase和Medline数据库中进行了结构化检索,以识别报告COPD和哮喘的发病率、患病率、医疗保健利用情况、发病率或死亡率的研究。
本研究共纳入19项研究。在人群研究和基于医院的研究中,COPD重叠的合并患病率分别为27%(95%CI:0.16 - 0.38,p<0.0001)和28%(95%CI:0.09 - 0.47,p = 0.0032)。我们发现ACOS和COPD在性别、吸烟状况、肺功能和6分钟步行距离方面无显著差异。然而,与仅患有COPD的受试者相比,ACOS受试者明显更年轻,体重指数更高,医疗保健利用率更高,健康相关生活质量更低。
ACOS是一种常见情况,存在于相当比例的COPD患者中。ACOS代表一种独特的临床表型,与单独的任何一种疾病相比,其急性加重、住院更频繁,健康相关生活质量更差,医疗费用更高。迫切需要更好地定义该综合征的管理和治疗方法。